OrthoPediatrics Corp. (KIDS) vs Monopar Therapeutics Inc. (MNPR)

A side-by-side comparison of OrthoPediatrics Corp. and Monopar Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KIDS vs MNPR

growth of $100 · dividends reinvested · last 7y
KIDS -45.5% (-8.3%/yr)MNPR -40.9% (-7.2%/yr)MNPR compounded faster over this window
050100150Start $100202120232025$55$59
KIDS MNPR

KIDS vs MNPR: by the numbers

  • •KIDS is the larger company ($584M vs $546M market cap).
  • •Both run net losses; MNPR's is the smaller (0.00% vs -15.72% net margin).

Metrics side by side

Valuation

MetricKIDSMNPR
P/S ratio2.31N/A
P/B ratio1.704.17

Profitability

MetricKIDSMNPR
Gross margin73.65%0.00%
Operating margin-9.01%0.00%
Net margin-15.72%0.00%
ROE-11.56%-13.64%
ROIC-4.97%-16.89%

Growth (annualized)

MetricKIDSMNPR
Revenue CAGR (5Y)23.14%N/A
Total return CAGR (5Y)-18.40%27.38%

Frequently asked

How have KIDS and MNPR total returns compared?
Over the past 5 years, KIDS delivered -18.40% and MNPR delivered 27.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.